FreeTender
Deadline not statedgrantUnited States

Applications open for NIAMS P30 Centers Program in the United States

Published
14 Oct 2026
Reference
applications-open-for-niams-p30-centers-program-in-the-united-states
Location
United States
Sector
Healthcare & Pharma

At a glance

A buyer in United States has published a funding call in healthcare & pharma: “Applications open for NIAMS P30 Centers Program in the United States”. The notice does not state a closing date, so confirm the timetable on the official portal. Quote reference applications-open-for-niams-p30-centers-program-in-the-united-states in any correspondence with the buyer. There are 362 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.

Details

The National Institutes of Health (NIH) invites applications for the NIAMS P30 Centers Program, which supports research centers focusing on skin biology and diseases, musculoskeletal and orthopaedic research, and rheumatic diseases. This program aims to enhance scientific discovery, research efficiency, and the translation of findings into improved health outcomes. Applications are open until March 27, 2027. The NIAMS P30 Centers Program aims to create integrated research centers that offer coordinated research infrastructure and shared resources to advance basic, translational, and clinical research. The program encourages multidisciplinary collaboration and supports workforce development in emerging research areas, such as data science and artificial intelligence. Eligible applicants include, but are not limited to:

The program supports centers that:

This opportunity provides significant funding to support research centers that can drive advancements in health research areas crucial for understanding and treating diseases affecting the skin, bones, and rheumatic systems. The program also fosters collaboration across disciplines and career stages, contributing to the overall enhancement of research capacity and effectiveness. For additional information, contact the National Institute of Arthritis and Musculoskeletal and Skin Diseases at [contact details removed]. Interested applicants should review the official guidelines and prepare their applications according to the specified requirements. Ensure timely submission through the appropriate channels to be considered for this funding opportunity. For more information, visit Grants.gov.

This notice has closed — what to do next

There are 362 open Healthcare & Pharma tenders in United States.

Browse all open Healthcare & Pharma tenders →

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the closing date and submission window on the official portal before you start preparing your bid.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →